FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308507974> ?p ?o ?g. }

• W4308507974 endingPage "70" @default.
• W4308507974 startingPage "64" @default.
• W4308507974 abstract "Viral diseases of bees, in particular the sac brood, are an urgent problem of the industry, which brings great losses. The situation worsens in the case of parallel infestation of insects by the Varroa mite. Today, a complex approach is used for the treatment of viral diseases of bees, which is based on a connection of antiviral and antiparasitic measures in combination with drugs that have general strengthening and biostimulating effects. Nevertheless, the issue of developing ecologically safe and effective schemes for the prevention and treatment of bee diseases, in particular viral ones, is relevant today. In this work, the positive effect of using a specific probiotic for bees “Apinormin” for sac brood was investigated. Research in laboratory conditions was carried out on bees of the summer generation, selected into cages. The oral effect of the drug was determined by feeding bees with sugar syrup, the contact effect by spraying the body of insects with an aqueous solution in concentrations of 0.4; 0.8; 4.0; 8.0 %. Under natural conditions, the therapeutic effectiveness of a 4 % solution of “Apinormin” compared to the creation of an infertile period for the period of removal of queens for bee sac brood was determined. In laboratory conditions, the drug was proven to be harmless for bees when used orally in all tested concentrations. It has been established that “Apinormin” significantly increases the life expectancy of insects. Thus, feeding an 8 % probiotic solution slowed down the process of natural dying of bees from 7.24 to 27.75 % in the dynamics of observations. Under natural conditions, the drug did not show an antiviral effect. The effectiveness of the infertile period in the treatment of this viral disease is shown. The obtained positive effect of “Apinormin” on the life extension of bees and the presence of a number of biologically active compounds in its composition serve as a basis for the use of the drug to increase the strength and productivity of families, in case of stress, protein starvation, various technological violations of maintenance and the development of schemes for the prevention and treatment of bacterial diseases of bees. The expediency of using the infertile period for the period of removal of the queens in the following studies, both for self-administration and for working out the schemes of complex therapy of infectious diseases of bees together with the appropriate veterinary drugs, is substantiated." @default.
• W4308507974 created "2022-11-12" @default.
• W4308507974 creator A5000299450 @default.
• W4308507974 creator A5012442748 @default.
• W4308507974 creator A5058865345 @default.
• W4308507974 creator A5085588180 @default.
• W4308507974 creator A5091238416 @default.
• W4308507974 date "2022-10-21" @default.
• W4308507974 modified "2023-10-18" @default.
• W4308507974 title "Harmlessness, biostimulating and antiviral action of probiotic “Apinormin” for honey bees" @default.
• W4308507974 doi "https://doi.org/10.32718/nvlvet10711" @default.
• W4308507974 hasPublicationYear "2022" @default.
• W4308507974 type Work @default.
• W4308507974 citedByCount "0" @default.
• W4308507974 crossrefType "journal-article" @default.
• W4308507974 hasAuthorship W4308507974A5000299450 @default.
• W4308507974 hasAuthorship W4308507974A5012442748 @default.
• W4308507974 hasAuthorship W4308507974A5058865345 @default.
• W4308507974 hasAuthorship W4308507974A5085588180 @default.
• W4308507974 hasAuthorship W4308507974A5091238416 @default.
• W4308507974 hasBestOaLocation W43085079741 @default.
• W4308507974 hasConcept C114265396 @default.
• W4308507974 hasConcept C147490343 @default.
• W4308507974 hasConcept C18903297 @default.
• W4308507974 hasConcept C2777096740 @default.
• W4308507974 hasConcept C2779381614 @default.
• W4308507974 hasConcept C2780255968 @default.
• W4308507974 hasConcept C2780871575 @default.
• W4308507974 hasConcept C33070731 @default.
• W4308507974 hasConcept C523546767 @default.
• W4308507974 hasConcept C54355233 @default.
• W4308507974 hasConcept C86803240 @default.
• W4308507974 hasConcept C90856448 @default.
• W4308507974 hasConceptScore W4308507974C114265396 @default.
• W4308507974 hasConceptScore W4308507974C147490343 @default.
• W4308507974 hasConceptScore W4308507974C18903297 @default.
• W4308507974 hasConceptScore W4308507974C2777096740 @default.
• W4308507974 hasConceptScore W4308507974C2779381614 @default.
• W4308507974 hasConceptScore W4308507974C2780255968 @default.
• W4308507974 hasConceptScore W4308507974C2780871575 @default.
• W4308507974 hasConceptScore W4308507974C33070731 @default.
• W4308507974 hasConceptScore W4308507974C523546767 @default.
• W4308507974 hasConceptScore W4308507974C54355233 @default.
• W4308507974 hasConceptScore W4308507974C86803240 @default.
• W4308507974 hasConceptScore W4308507974C90856448 @default.
• W4308507974 hasIssue "107" @default.
• W4308507974 hasLocation W43085079741 @default.
• W4308507974 hasOpenAccess W4308507974 @default.
• W4308507974 hasPrimaryLocation W43085079741 @default.
• W4308507974 hasRelatedWork W1543599882 @default.
• W4308507974 hasRelatedWork W208221531 @default.
• W4308507974 hasRelatedWork W2105443051 @default.
• W4308507974 hasRelatedWork W2266801752 @default.
• W4308507974 hasRelatedWork W2296773627 @default.
• W4308507974 hasRelatedWork W2339884932 @default.
• W4308507974 hasRelatedWork W2416162817 @default.
• W4308507974 hasRelatedWork W347912395 @default.
• W4308507974 hasRelatedWork W4385724442 @default.
• W4308507974 hasRelatedWork W3142862862 @default.
• W4308507974 hasVolume "24" @default.
• W4308507974 isParatext "false" @default.
• W4308507974 isRetracted "false" @default.
• W4308507974 workType "article" @default.